LYPHF
Price
$0.27
Change
+$0.01 (+3.85%)
Updated
Apr 11 closing price
Capitalization
1.67B
OGN
Price
$9.18
Change
-$0.02 (-0.22%)
Updated
Aug 28 closing price
Capitalization
2.39B
62 days until earnings call
Interact to see
Advertisement

LYPHF vs OGN

Header iconLYPHF vs OGN Comparison
Open Charts LYPHF vs OGNBanner chart's image
Luye Pharma Group
Price$0.27
Change+$0.01 (+3.85%)
Volume$3.73K
Capitalization1.67B
Organon & Co
Price$9.18
Change-$0.02 (-0.22%)
Volume$3.47M
Capitalization2.39B
LYPHF vs OGN Comparison Chart in %
Loading...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYPHF vs. OGN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYPHF is a Hold and OGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (LYPHF: $0.27 vs. OGN: $9.18)
Brand notoriety: LYPHF and OGN are both not notable
LYPHF represents the Pharmaceuticals: Generic, while OGN is part of the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LYPHF: 100% vs. OGN: 85%
Market capitalization -- LYPHF: $1.67B vs. OGN: $2.39B
LYPHF [@Pharmaceuticals: Generic] is valued at $1.67B. OGN’s [@Pharmaceuticals: Major] market capitalization is $2.39B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYPHF’s FA Score shows that 0 FA rating(s) are green whileOGN’s FA Score has 1 green FA rating(s).

  • LYPHF’s FA Score: 0 green, 5 red.
  • OGN’s FA Score: 1 green, 4 red.
According to our system of comparison, OGN is a better buy in the long-term than LYPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGN’s TA Score shows that 5 TA indicator(s) are bullish.

  • OGN’s TA Score: 5 bullish, 5 bearish.

Price Growth

LYPHF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while OGN (@Pharmaceuticals: Major) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.15%. For the same industry, the average monthly price growth was +68.06%, and the average quarterly price growth was +81.85%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.89%. For the same industry, the average monthly price growth was +1.22%, and the average quarterly price growth was +11.81%.

Reported Earning Dates

OGN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.15% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Pharmaceuticals: Major (-1.89% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGN($2.39B) has a higher market cap than LYPHF($1.67B). LYPHF has higher P/E ratio than OGN: LYPHF (15.33) vs OGN (3.42). LYPHF YTD gains are higher at: -22.025 vs. OGN (-37.061).
LYPHFOGNLYPHF / OGN
Capitalization1.67B2.39B70%
EBITDAN/A1.5B-
Gain YTD-22.025-37.06159%
P/E Ratio15.333.42448%
RevenueN/A6.28B-
Total CashN/A599M-
Total DebtN/A8.9B-
TECHNICAL ANALYSIS
Technical Analysis
LYPHFOGN
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
72%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
5%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
5%
Bearish Trend 1 day ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
67%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
73%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
65%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SLVAX37.59N/A
N/A
Columbia Select Large Cap Value A
ACIHX67.10N/A
N/A
American Century Growth G
CRFRX12.02N/A
N/A
Calvert Focused Value R6
ARYNX13.70N/A
N/A
American Century Global Real Estate I
ALOCX18.92N/A
N/A
Alger Mid Cap Focus C

LYPHF and

Correlation & Price change

A.I.dvisor tells us that LYPHF and OGN have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYPHF and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYPHF
1D Price
Change %
LYPHF100%
N/A
OGN - LYPHF
4%
Poorly correlated
-0.22%
SNYNF - LYPHF
3%
Poorly correlated
N/A
CSWYF - LYPHF
1%
Poorly correlated
N/A
VRBCF - LYPHF
-0%
Poorly correlated
N/A
JCRRF - LYPHF
-1%
Poorly correlated
N/A
More

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
-0.22%
BIIB - OGN
40%
Loosely correlated
-2.72%
GSK - OGN
38%
Loosely correlated
-1.18%
SNY - OGN
36%
Loosely correlated
-0.34%
JNJ - OGN
36%
Loosely correlated
-0.76%
LLY - OGN
35%
Loosely correlated
-0.30%
More